Exodus Point Capital Management, LP Mei Pharma, Inc. Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$2.46 - $4.27 $52,152 - $90,523	-21,200 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.45 - $4.3 $30,740 - $91,160	21,200 New	21,200 $88,000
Q2 2019 Aug 14, 2019	SELL	$2.45 - $3.32 $409,451 - $554,848	-167,123 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.52 - $3.24 $279,974 - $359,967	111,101 Added 198.32%	167,123 $513,000
Q4 2018 Feb 14, 2019	BUY	$1.92 - $4.1 $107,562 - $229,690	56,022 New	56,022 $148,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $366M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.